A detailed history of Acadian Asset Management LLC transactions in Relay Therapeutics, Inc. stock. As of the latest transaction made, Acadian Asset Management LLC holds 28,947 shares of RLAY stock, worth $86,551. This represents 0.0% of its overall portfolio holdings.

Number of Shares
28,947
Holding current value
$86,551
% of portfolio
0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 11, 2025

BUY
$4.12 - $6.8 $119,261 - $196,839
28,947 New
28,947 $118,000
Q4 2023

Feb 13, 2024

BUY
$6.01 - $11.48 $23,288 - $44,485
3,875 New
3,875 $42,000
Q3 2022

Nov 14, 2022

BUY
$18.07 - $31.37 $31,514 - $54,709
1,744 New
1,744 $38,000
Q3 2022

Nov 14, 2022

BUY
$18.07 - $31.37 $31,514 - $54,709
1,744 New
1,744 $38,000

Others Institutions Holding RLAY

About Relay Therapeutics, Inc.


  • Ticker RLAY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 120,219,000
  • Market Cap $359M
  • Description
  • Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...
More about RLAY
Track This Portfolio

Track Acadian Asset Management LLC Portfolio

Follow Acadian Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acadian Asset Management LLC with notifications on news.